Delivery Order SPE2DB22D3501-SPE2DB23FWJ42
Award Date 7/12/23
Potential Completion Date 7/13/23
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $34,669.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits, with an ultimate completion date of July 24, 2025. This competitively awarded contract, issued on July 23, 2025, carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $22,385.72 to AmerisourceBergen Drug Corp for the supply of Betaseron 0.3 mg kits under a firm fixed price contract. This competitively awarded, non-set-aside delivery order was executed on September 9, 2025, with an ultimate completion date of September 10, 2025. The products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and pharmaceutical...
- The Defense Logistics Agency awarded a $39,862.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Betaseron 0.3 mg kits. The delivery order is scheduled for completion by December 8, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal procurement standards....
- The Defense Logistics Agency awarded a delivery order valued at $7,923.50 to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits on November 18, 2025, with completion expected by November 19, 2025. This competitively awarded, firm fixed-price contract represents a small-value transaction under the company's larger pharmaceutical supply relationship with the federal government. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $11,859.47 to AmerisourceBergen Drug Corp for the supply of Betaseron 0.3 mg kits. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 25, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs....
- The Defense Logistics Agency has awarded a delivery order valued at $59,367.66 to AmerisourceBergen Drug Corp for the supply of Betaseron 0.3 mg kits. This firm fixed-price delivery order, issued on September 24, 2025, with completion expected by September 25, 2025, represents a non-competitive set-aside arrangement and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability...
- The Defense Logistics Agency awarded a $42,977.95 firm fixed price delivery order to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits, with an ultimate completion date of December 17, 2025. This non-set-aside contract represents a competitively awarded delivery order under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $31,415.33 delivery order to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits, with a completion date of October 30, 2025. This firm fixed price contract, awarded on October 29, 2025, represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, will supply this interferon beta-1b...
- The Defense Logistics Agency awarded a delivery order valued at $45,542.34 to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits, with an ultimate completion date of November 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 7, 2025, for $61,750.04 to supply Betaseron 0.3 mg kits. This is a firm fixed-price delivery order with an ultimate completion date of July 8, 2025, and performance will be executed at the contractor's Conshohocken, Pennsylvania facility. The award was made without a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, a major...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB23FWJ42Delivery Order
The Defense Logistics Agency awarded a firm fixed price delivery order valued at thirteen thousand four hundred ninety-nine dollars and ninety-four cents ($13,499.94) to Amerisourcebergen Drug Corporation for 4561479328 units of Betaseron 0.3 mg kits. Performance will take place in Conshohocken, Pennsylvania under a one day period from July 12, 2023 through July 13, 2023. As a major provider of medical supplies and pharmaceuticals to the Department of Defense, this order for the multiple sclerosis treatment drug supports the Agency's mission to provide optimal healthcare support to military members and their families.
Generated 12/23/23, 2:01 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.5k | 7/12/23 |